BullishAgent BullishAgent SEC Filings Earnings Calendar Analyst Ratings IPOs Insiders Institutional Funds Screener
Sign in Register

HELP

Cybin Inc. Common Stock NASDAQ
Healthcare ·Biotechnology ·CA · cybin.com
$5.29
Mkt Cap $263.9M
52w Low $4.29 18.1% of range 52w High $9.83
50d MA $5.56 200d MA $6.46
P/E (TTM) -8.4x
EV/EBITDA -0.3x
P/B 0.4x
Debt/Equity 0.0x
ROE
P/FCF -1.7x
RSI (14)
ATR (14)
Beta 1.04
50d MA $5.56
200d MA $6.46
Avg Volume 1.1M
About
Clinical-stage biopharmaceutical company developing psychedelic-based therapeutics including CYB003 (deuterated psilocybin analog) for major depressive disorder and CYB004 (deuterated DMT) for generalized anxiety disorder
Recent Earnings
Date Time Est Rptd Surp Base Gap% D1% D2% D3% D4% D5% Guide ▲★
Feb 16, 2026 AMC -0.76 -0.99 -30.5%
Feb 13, 2026 AMC -0.53 -0.72 -35.8% 6.09 +5.1% +11.0% +16.6% +13.3% +11.8% +10.5%
Nov 13, 2025 AMC -0.74 -1.39 -87.8%
Aug 13, 2025 AMC -0.96 -1.10 -14.7%
Nov 13, 2024 AMC -0.98 -2.86 -190.9%
Aug 8, 2024 AMC -0.97 -0.12 +88.0%
Mar 31, 2024 AMC -0.17
Feb 14, 2024 AMC -1.22 -0.24 +80.5%
Nov 15, 2023 AMC -0.05
Aug 14, 2023 AMC -0.06
Recent Analyst Ratings
Date Firm Action Grade Target Base Open Gap% D1% D2% D3% D4% D5%
Mar 2 HC Wainwright & Co. Maintains Buy → Buy $7.35 $7.15 -2.7% +3.5% +7.5% +16.1% -23.3% -28.6%
Dec 3 Guggenheim Maintains Buy → Buy
Nov 20 Canaccord Genuity Maintains Buy → Buy
Nov 14 HC Wainwright & Co. Maintains Buy → Buy
Data updated apr 25, 2026 1:18pm · Source: massive.com